Показано 0 из 0
Дата |
---|
16.05.2024 |
22.12.2023 |
13.12.2023 |
04.10.2023 |
27.09.2023 |
13.09.2023 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
|
463.70
|
463.70
|
463.70
|
|
|
1 206 547.40
|
|
|
|
|
|
|
493.03
|
|
|
293 625.00
|
|
|
|
|
|
|
493.03
|
|
|
21 000.00
|
|
|
|
|
493.03
|
493.03
|
493.03
|
|
|
80 856.92
|
|
|
|
|
504.14
|
504.14
|
504.14
|
|
|
265 177.64
|
|
|
|
|
487.90
|
487.90
|
487.90
|
|
|
821 135.70
|
|
Fortrea Holdings Inc operates as a holding company. The Company, through its subsidiaries, provides phase I through IV clinical trial management, clinical pharmacology, patient access solutions, and other enabling services. Fortrea Holdings partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.